India piperacillin/tazobactam market is expected to grow at a substantial rate during the forecast period. The India piperacillin/tazobactam market is driven by use of these drugs for treating various infections such as nosocomial pneumonia. It is a combinational drug for which the tazobactam is added to beta-lactam antibiotic piperacillin to make it more effective against organisms that express beta-lactamase and would normally degrade piperacillin. Additionally, supportive government policies and improving healthcare infrastructure are some other reasons that are expected to create lucrative opportunities for the market growth over the next few years.


The India piperacillin/tazobactam market is segmented based on route of administration, distribution channel, source, application, end user, company and region. Based on source, the market can be split into in-house and contract manufacturing organizations. Out of which, the in-house segment dominated the market until 2017 owing to in house production preference by the major market players. The contract manufacturing organizations segment is expected to witness significant growth during the forecast period on account of increased outsourcing activities by major companies in order to focus on their R&D activity and expansion plans. Additionally, contract manufacturing organizations offer competitive pricing and can provide bulk orders in lesser duration.


The major players operating in the India piperacillin/tazobactam market are Aristo Pharmaceuticals Ltd, Radicura Pharmaceuticals Pvt. Ltd., Tauras Laboratories Pvt. Ltd., Taj Pharmaceuticals Ltd., Corona Remedies Pvt. Ltd., Bestochem Formulations (India) Pvt. Ltd., Alpa Laboratories Ltd., Medical Pharma Ltd., Cipla Ltd., Lupin Laboratories Ltd and others. Major companies are developing advanced technologies, receiving approvals from regulatory bodies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions, research collaborations and new product developments.

Years considered for this report:

Historical Years: FY2017-FY2020

Base Year: FY2021

Estimated Year: FY2022

Forecast Period: FY2023–FY2027

Objective of the Study:

  • To analyze historical growth in market size of India piperacillin/tazobactam market from FY2017 to FY2021.
  • To estimate and forecast the market size of India piperacillin/tazobactam market from FY2022 to FY2027 and growth rate until FY2027.
  • To classify and forecast India piperacillin/tazobactam market based on route of administration, distribution channel, source, application, end user, company and regional distribution.
  • To identify dominant region or segment in the India piperacillin/tazobactam market.
  • To identify drivers and challenges for India piperacillin/tazobactam market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India piperacillin/tazobactam market.
  • To identify and analyze the profiles of leading players operating in India piperacillin/tazobactam market.
  • To identify key sustainable strategies adopted by market players in India piperacillin/tazobactam market.

 

Click here to download the sample


TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India piperacillin/tazobactam market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated them through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research. 

Key Target Audience:

  • Piperacillin/tazobactam manufacturers/ suppliers/ distributors
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to piperacillin/tazobactam

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India piperacillin/tazobactam market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Piperacillin/Tazobactam Market, By Route of Administration:
    • Intravenous injection
    • Intramuscular injection
  • India Piperacillin/Tazobactam Market, By Distribution Channel:
    • Online
    • Offline
  • India Piperacillin/Tazobactam Market, By Source:
    • In-House
    • Contract Manufacturing Organizations
  • India Piperacillin/Tazobactam Market, By Application:
    • Intra-abdominal Infections
    • Nosocomial Pneumonia
    • Skin and Skin Structure Infections
    • Community Acquired Pneumonia
    • Others
  • India Piperacillin/Tazobactam Market, By End User:
    • Adult
    • Pediatric
  • India Piperacillin/Tazobactam Market, By Region:
    • North
    • South
    • East
    • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India piperacillin/tazobactam market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India piperacillin/tazobactam market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on India Piperacillin/Tazobactam Market

4.    Executive Summary

5.    Manufacturing of Piperacillin/Tazobactam

5.1.  Raw Material

5.2.  Machinery

5.3.  Manufacturing Methods

5.4.  Contact Details of Machinery & Raw Material Suppliers

6.    Pharmacodynamic Overview of Piperacillin/Tazobactam

6.1.  Mechanism of Action

6.2.  Absorption

6.3.  Volume of Distribution

6.4.  Protein Binding

6.5.  Metabolism

6.6.  Route of Elimination

6.7.  Half-Life

6.8.  Clearance

6.9.  Toxicity

7.    India Piperacillin/Tazobactam Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Route of Administration (Intravenous injection v/s Intramuscular Injection)

7.2.2.     By Distribution Channel (Online v/s Offline)

7.2.3.     By Source (In-house v/s Contract Manufacturing Organizations)

7.2.4.     By Application (Intra-abdominal Infections, Nosocomial Pneumonia, Skin and      Skin Structure Infections, Community Acquired Pneumonia and Others)

7.2.5.     By End User (Adult v/s Pediatric)

7.2.6.     By Region (North, East, South, West)

7.2.7.     By Company

7.3.  Product Market Map

8.    Market Dynamics

8.1.  Drivers

8.2.  Challenges

9.    Market Trends & Developments

10.  Policy & Regulatory Landscape

10.1.              Custom Duty & Taxes

10.2.              Government Subsidy & Benefits

10.3.              Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)

11.  Import & Export Analysis

12.  Pricing Analysis

13.  India Economic Profile

14.  Competitive Landscape

14.1.              Company Profiles

14.1.1.  Aristo Pharmaceuticals Ltd.

14.1.1.1.      Company Brief

14.1.1.2.      Production Plants & Capacity (If Available)

14.1.1.3.      Financials (If Available)

14.1.1.4.      Captive Consumption Vs Merchant Sale

14.1.1.5.      Current & Future Plans

14.1.2.  Radicura Pharmaceuticals Pvt. Ltd.

14.1.3.  Tauras Laboratories Pvt. Ltd.

14.1.4.  Taj Pharmaceuticals Ltd.

14.1.5.  Corona Remedies Pvt. Ltd.

14.1.6.  Bestochem Formulations (India) Pvt. Ltd.

14.1.7.  Alpa Laboratories Ltd.

14.1.8.  Medical Pharma Ltd.

14.1.9.  Cipla Ltd.

14.1.10. Lupin Laboratories Ltd.

15.  Strategic Recommendations

16.  About Us & Disclaimer

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com